deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01443104

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

A Randomized Comparison of a Sirolimus-eluting Stent With Biodegradable Polymer Versus an Everolimus-eluting Stent With a Durable Polymer for Percutaneous Coronary Revascularization

Sponsor: Biotronik AG

Conditions Angina Pectoris Coronary Artery Disease Myocardial Infarction
Interventions Everolimus-eluting stent with a durable polymer Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
Updated 9 times since 2017 Last updated: Oct 16, 2018 Started: Feb 29, 2012 Primary completion: Jun 30, 2014 Completion: Jun 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01443104, this NA trial focuses on Angina Pectoris and Coronary Artery Disease and remains completed. Sponsored by Biotronik AG, it has been updated 9 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotActive Not Recruiting~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2023 · 30 months · monthly snapshotCompleted~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jul 2023 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jul 2023 [monthly]

    Completed NA

▶ Show 4 earlier versions

  1. Nov 2018 — Jan 2021 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  2. Jun 2018 — Nov 2018 [monthly]

    Active Not Recruiting NA

  3. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

    Phase: PHASE4 → NA

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE4

    First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Biotronik AG
  • Insel Gruppe AG, University Hospital Bern
  • University of Bern
Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations